ENDRA Life Sciences Inc.
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $4.10
- 52-Week Range
- $2.96 – $6.80
- Market Cap
- $6.05M
- P/E (TTM)
- —
- EPS (TTM)
- -6.44
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.16
- PEG Ratio
- —
- Return on Equity
- -217.72%
- Return on Assets
- -100.64%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 7.95
- Debt/Equity
- 0.08
- Total Debt
- $396.54K
- Free Cash Flow
- —
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $4.93M
Market Snapshot
About
ENDRA Life Sciences Inc. develops medical imaging technology focused on TAEUS (Thermo-Acoustic Enhanced UltraSound), a thermoacoustic imaging approach for visualizing tissue composition. The company targets liver disease detection and other diagnostic applications.